Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: Dec. 2, 2013

AcelRx, Ampio, Biogen Idec, Exelixis, Idenix, Polaris

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Polaris to begin AML trial . . . read more

Phase II
Exelixis begins CRPC trial . . . read more

Idenix begins HCV trial . . . read more

Filings
Ampio study ruled pivotal for BLA . . . read more

Biogen Idec Alprolix PDUFA date delayed . . . read more

Zalviso NDA accepted by FDA . . . read more

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters